BlackRock’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
80,675
-19,954
| -20% | -$43.3K | ﹤0.01% | 4629 |
|
|
2025
Q1 | $151K | Sell |
100,629
-11,350
| -10% | -$17K | ﹤0.01% | 4613 |
|
|
2024
Q4 | $563K | Buy |
111,979
+10,484
| +10% | +$52.7K | ﹤0.01% | 4325 |
|
|
2024
Q3 | $818K | Buy |
101,495
+786
| +0.8% | +$6.34K | ﹤0.01% | 4171 |
|
|
2024
Q2 | $580K | Buy |
100,709
+3,080
| +3% | +$17.7K | ﹤0.01% | 4256 |
|
|
2024
Q1 | $1.16M | Buy |
97,629
+1,645
| +2% | +$19.6K | ﹤0.01% | 4103 |
|
|
2023
Q4 | $1.79M | Sell |
95,984
-297
| -0.3% | -$5.55K | ﹤0.01% | 4004 |
|
|
2023
Q3 | $914K | Sell |
96,281
-1,012
| -1% | -$9.6K | ﹤0.01% | 4211 |
|
|
2023
Q2 | $1.39M | Buy |
97,293
+3,047
| +3% | +$43.5K | ﹤0.01% | 4108 |
|
|
2023
Q1 | $1.45M | Sell |
94,246
-8,950
| -9% | -$138K | ﹤0.01% | 4118 |
|
|
2022
Q4 | $1.39M | Sell |
103,196
-41,253
| -29% | -$554K | ﹤0.01% | 4212 |
|
|
2022
Q3 | $1.98M | Sell |
144,449
-2,363
| -2% | -$32.4K | ﹤0.01% | 4118 |
|
|
2022
Q2 | $1.66M | Sell |
146,812
-881
| -0.6% | -$9.99K | ﹤0.01% | 4238 |
|
|
2022
Q1 | $1.97M | Buy |
147,693
+94
| +0.1% | +$1.26K | ﹤0.01% | 4319 |
|
|
2021
Q4 | $2.6M | Buy |
147,599
+44,269
| +43% | +$778K | ﹤0.01% | 4231 |
|
|
2021
Q3 | $3.28M | Buy |
103,330
+2,333
| +2% | +$74.1K | ﹤0.01% | 4057 |
|
|
2021
Q2 | $8.64M | Buy |
+100,997
| New | +$8.64M | ﹤0.01% | 3631 |
|